Abstract
Patients with significant valve disorders present coagulopathy induced by mechanical effects (valvular stenosis or valvular insufficiency). Besides, these populations need prophylactic use of antiplatelet drugs due to myocardial remodeling and antiarrhythmic conditions that may be associated. Patients with severe aortic stenosis may also acquire vonWillebrand disease type 2A due to proteo…